Clinical trial
Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial
NCT02258919 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- May 23, 2024
- Enrollment
- 201 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.